Management of hepatitis C infection before and after liver transplantation (Q28081250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

review article

1 reference

title

Management of hepatitis C infection before and after liver transplantation (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

main subject

liver transplantation

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1

Stefano Fagiuoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

7

Luisa Pasulo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

Maria Grazia Lucà

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Roberto Ravasio

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Anna Baldan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Alessandro Vitale

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

1 reference

1 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

6 March 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

21

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

15

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

4447-4456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

Emerging therapies for hepatitis C

6 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Strategies to reduce hepatitis C virus recurrence after liver transplantation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 results

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Treatment of chronic hepatitis C virus infection after liver transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Pretransplant and posttransplant treatment of hepatitis C virus infection with protease inhibitors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

OPTN/SRTR 2011 Annual Data Report: liver

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Antiviral strategies in hepatitis C virus infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Hepatitis C virus treatment pre- and post-liver transplantation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Management of hepatitis C virus infection recurrence after liver transplantation: an overview.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Treatment of HCV infection in patients with cirrhosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

The natural history of recurrent hepatitis C and what influences this

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Role of growth factors in the treatment of patients with HIV/HCV coinfection and patients with recurrent hepatitis C following liver transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

New approaches and therapeutic modalities for the prevention and treatment of recurrent HCV after liver transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Histology predicts cirrhotic evolution of post transplant hepatitis C

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

The natural history of hepatitis C cirrhosis after liver transplantation

2 June 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Impact of conversion from pegylated interferon-α2b to interferon-α2a for treating recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I15.4447

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4402292

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

27 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25914454

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period

1 reference

https://pubmed.ncbi.nlm.nih.gov/25914454

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V21.I15.4447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25914454%20AND%20SRC:MED&resulttype=core&format=json